Table 3 Clinical description of study patients
ID patient | Age (years) | Sex | Ocular pathologies | Systemic comorbidities | Duration of illness (days from onset) | Mechanical ventilation | Clinical severity score* |
|---|---|---|---|---|---|---|---|
CoV-1 | 84 | M | None | Alcoholism | 4 | No | 1 |
CoV-2 | 84 | F | None | Alzheimer’s, kidney disease, arterial hypertension | 2 | Yes | – |
CoV-3 | 83 | M | Drusen | Hypertensive heart disease | 19 | No | 0 |
CoV-4 | 64 | M | None | None | 32 | Yes | 2 |
CoV-5 | 71 | F | None | None | 36 | No | 0 |
CoV-6 | 67 | M | None | Metastatic prostate cancer in radiotherapy treatment and androgen suppression therapy, arterial hypertension | 16 | Yes | 2 |
CoV-7 | 63 | M | POAG | Arterial hypertension, ulcerative colitis | 45 | Yes | 2 |
CoV-8 | 90 | M | None | Arterial hypertension, diabetes mellitus | 15 | No | 2 |
CoV-9 | 90 | M | None | Dyslipidemia, high blood pressure, benign prostatic hyperplasia, colonic neoplasia | 12 | No | 2 |
CoV-10 | 88 | M | Intermediate AMD | Alzheimer’s disease | 23 | No | 0 |
CoV-11 | 91 | F | Dry eye | Arterial hypertension, dyslipidemia, ischemic cardiomyopathy, Alzheimer’s disease, ictus | 36 | No | 1 |
CoV-12 | 92 | F | Geographic atrophy AMD | Arterial hypertension, dyslipidemia, COPD, benign prostatic hyperplasia | 13 | No | 1 |
CoV-13 | 88 | F | None | Dyslipidemia, Alzheimer’s disease, atrial fibrillation, ictus | 4 | No | – |
CoV-14 | 98 | F | None | Arterial hypertension, dyslipidemia, tachycardia arrhythmia, | 16 | No | 0 |
CoV-15 | 84 | M | Geographic atrophy AMD, POAG | Arterial hypertension, diabetes mellitus | 40 | No | 2 |
CoV-16 | 91 | F | None | Arterial hypertension, Alzheimer’s disease, atrial fibrillation | - | No | 0 |
Control-1 | 72 | F | None | Arterial hypertension | – | N/A | – |
Control-2 | 70 | M | None | Arterial hypertension, cardiopathy | – | N/A | – |
Control-3 | 74 | M | None | Arterial hypertension, auricular fibrillation, hyperuricemia | – | N/A | – |
Control-4 | 64 | M | None | None | – | N/A | – |
Control-5 | 74 | M | None | Arterial hypertension | – | N/A | – |
Control-6 | 79 | M | None | Arterial hypertension, myocardiopathy, lobectomy by bronchogenic carcinoma | – | N/A | – |
Control-7 | 57 | M | None | None | – | N/A | – |
Control-8 | 72 | F | None | None | – | N/A | – |
Control-9 | 78 | M | None | Arterial hypertension, benign prostatic hyperplasia, lung cancer | – | N/A | – |
Control-10 | 77 | M | None | N/A | – | N/A | – |
Control-11 | 70 | F | None | Oncologic patient | – | N/A | – |
Control-12 | 53 | F | None | N/A | – | N/A | – |
Control-13 | 57 | F | None | Arterial hypertension | – | N/A | – |
Control-14 | 65 | M | None | None | – | N/A | – |
Control-15 | 62 | M | None | None | – | N/A | – |